http://healthtech.com/mrn/overview.aspx
microRNA in Human Disease & Development
Register by January 9 and Save Up to $350!
COVERAGE INCLUDES:
microRNA Pathways and Mechanisms
microRNA in Human Development and Disease
microRNA Biomarkers for Diagnostics
microRNA Targets for Therapeutics
Special Focus: microRNA in Cancer
SHORT COURSE:
microRNA Identification, Profiling and Validation Techniques
FACULTY LIST:
Andreas G. Bader, Ph.D., Senior Scientist, Mirna Therapeutics, Inc.
Don A. Baldwin, Ph.D., Director, Penn Genomics Facility, University of Pennsylvania
Michele Cleary, Ph.D., Director, Biology, Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co., Inc.
John P. Cogswell, Ph.D., Genetics Consultant, GlaxoSmithKline
Dalia Cohen, Ph.D., Chief Scientific Officer, Rosetta Genomics, Inc.
Christoph Eicken Ph.D., Head, Technical Services Microarrays, LC Sciences LLC
Aurora Esquela-Kerscher, Ph.D., Assistant Professor, Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School
Richard Gregory, Ph.D., Assistant Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Stem Cell Institute, The Stem Cell Program at Children's Hospital Boston, Harvard Medical School
Qihong Huang, M.D., Ph.D., Assistant Professor, Systems Biology, Molecular and Cellular Oncogenesis Program, Wistar Institute
Jingfang Ju, Ph.D., Associate Professor and Co-Director, Translational Research Laboratory, Department of Pathology, Stony Brook University Medical Center
Marianthi Kiriakidou, M.D., Assistant Professor, Medicine, University of Pennsylvania School of Medicine
Sean Lawler, Ph.D., Assistant Professor, Neurological Surgery, Ohio State University
Harvey F. Lodish, Ph.D., Member, Whitehead Institute for Biomedical Research; Professor, Biology & Bioengineering, Massachusetts Institute of Technology
Li Ma, Ph.D., Life Sciences Research Foundation Fellow, Weinberg Lab, Whitehead Institute/Massachusetts Institute of Technology
Muthiah Manoharan, Ph.D., Vice President, Drug Discovery, Alnylam Pharmaceuticals, Inc.
Pieter Mestdagh, Ph.D., Center for Medical Genetics Ghent, Ghent University Hospital
Søren Møller, Ph.D., Vice President, Research & Development, Exiqon A/S
Mahendra S. Rao, Ph.D., Vice President, Stem Cells and Regenerative Medicine, Invitrogen
Isidore Rigoutsos, Ph.D., Manager, Bioinformatics & Pattern Discovery Group, Computational Biology Center, Deep Computing Institute, IBM Thomas J. Watson Research Center
Aldo Roccaro, M.D., Ph.D., Instructor in Medicine, Harvard Medical School
Hannele Ruohola-Baker, Ph.D., Professor, Biochemistry, University of Washington;
Aaron J. Schetter, Ph.D., M.P.H., Postdoctoral Fellow, Laboratory of Human Carcinogenesis, National Cancer Institute
Frank Slack, Ph.D., Associate Professor, Department of Molecular, Cellular and Developmental Biology, Yale University
Neil Smalheiser, M.D., Ph.D., Associate Professor, Psychiatry, University of Illinois at Chicago
Juergen Soutschek, Ph.D., Senior Director, Scientific Development, Regulus Therapeutics
Samuil Umansky, M.D., Ph.D., Chief Scientific Officer, Xenomics, Inc.
Eva van Rooij, Ph.D., Department of Molecular Biology, University of Texas Southwestern Medical Center; Director, Preclinical Research, miRagen Therapeutics, Inc.
Francois Vigneault, Ph.D., Church Laboratory, Department of Genetics, Harvard Medical School
Elena Vigorito, Ph.D., Group Leader, The Babraham Institute, UK
Eugenia Wang, Ph.D., Gheens Endowed Chair in Aging, University of Louisville
Mike Wilson, Ph.D., Senior Scientist, Asuragen, Inc.
Lin Zhang, M.D., Research Assistant Professor, Center for Research on the Early Detection & Cure of Ovarian Cancer, Center for Research on Reproduction and Women's Health, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine